Morpholin-4-yl-[3-[[(2R)-1-(pyridin-3-ylmethyl)piperidin-2-yl]methyl]-1-benzothiophen-2-yl]methanone
C25H29N3O2S — CID 95839959
Data last refreshed: (MolForge compound catalog, from PubChem)
About Morpholin-4-yl-[3-[[(2R)-1-(pyridin-3-ylmethyl)piperidin-2-yl]methyl]-1-benzothiophen-2-yl]methanone
Morpholin-4-yl-[3-[[(2R)-1-(pyridin-3-ylmethyl)piperidin-2-yl]methyl]-1-benzothiophen-2-yl]methanone (PubChem CID 95839959) has the molecular formula C25H29N3O2S and a molecular weight of 435.59 g/mol. Its IUPAC name is morpholin-4-yl-[3-[[(2R)-1-(pyridin-3-ylmethyl)piperidin-2-yl]methyl]-1-benzothiophen-2-yl]methanone.
Molecular Properties
| Compound Name | Morpholin-4-yl-[3-[[(2R)-1-(pyridin-3-ylmethyl)piperidin-2-yl]methyl]-1-benzothiophen-2-yl]methanone |
|---|---|
| PubChem CID | 95839959 |
| Molecular Formula | C25H29N3O2S |
| Molecular Weight | 435.59 g/mol |
| Exact Mass | 435.20 |
| IUPAC Name | morpholin-4-yl-[3-[[(2R)-1-(pyridin-3-ylmethyl)piperidin-2-yl]methyl]-1-benzothiophen-2-yl]methanone |
| SMILES | O=C(c1sc2ccccc2c1C[C@H]1CCCCN1Cc1cccnc1)N1CCOCC1 |
| InChI | InChI=1S/C25H29N3O2S/c29-25(27-12-14-30-15-13-27)24-22(21-8-1-2-9-23(21)31-24)16-20-7-3-4-11-28(20)18-19-6-5-10-26-17-19/h1-2,5-6,8-10,17,20H,3-4,7,11-16,18H2/t20-/m1/s1 |
| InChIKey | WVGOGHSDAYNYPN-HXUWFJFHSA-N |
| XLogP | 4.37 |
| TPSA | 45.67 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 435.59 |
| LogP ≤ 5 | 4.37 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 95839959 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.